Requirement for NF-κB in osteoclast and B-cell development

Genes and Development

Volumn 11, Issue 24, 1997, Pages 3482-3496

  Franzoso, Guido ^a,d   Carlson, Louise ^a   Xing, Lianping ^b   Poljak, Ljiljana ^a   Shores, Elizabeth W ^c   Brown, Keith D ^a   Leonardi, Antonio ^a   Tran, Tom ^c   Boyce, Brendan F ^b   Siebenlist, Ulrich ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

B cell; Development; Knockout mice; NF B; Osteoclasts; Osteopetrosis

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADOPTIVE TRANSFER; ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; FETUS; HOST RESISTANCE; MACROPHAGE; MOUSE; NEWBORN; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SPLEEN; THYMUS; ANIMAL; GENETICS; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; B-LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; OSTEOCLASTS; OSTEOPETROSIS; SPLEEN; THYMUS GLAND;

EID: 15444357762     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.24.3482     Document Type: Article

References (83)

1. Agger, R., M. Witmer-Pack, N. Romani, H. Stossel, W.J. Swiggard, J.P. Metlay, E. Storozynsky, P. Freimuth, and R.M. Steinman. 1992. Two populations of splenic dendritic cells detected with M342, a new monoclonal antibody to an intracellular antigen of interdigitating dendritic cells and some B lymphocytes. J. Leukocyte Biol. 52: 34-42.
2. Anderson, G., N.C. Moore, J.J. Owen, and E.J. Jenkinson. 1996. Cellular interactions in thymocyte development. Annu. Rev. Immunol. 14: 73-99.
3. Baeuerle, P.A. and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
4. Baldwin, A.S. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14: 649-681.
5. Beg, A.A. and D. Baltimore. 1996. An esssential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782-784.
6. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995a. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes & Dev. 9: 2736-2746.
7. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995b. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376: 167-170.
8. Belvin, M.P. and K.V. Anderson. 1996. A conserved signaling pathway: The Drosophila toll-dorsal pathway. Annu. Rev. Cell. Dev. Biol. 12: 393-416.
9. Boothby, M.R., A.L. Mora, D.C. Scherer, J.A. Brockman, and D.W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive respressor of nuclear factor (NF)-κB. J. Exp. Med. 185: 1897-1907.
10. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through IκB motifs via association with DNA-binding p50B homodimers. Cell 72: 729-739.
11. Boyce, B.F., T. Yoneda, C. Lowe, P. Soriano, and G.R. Mundy. 1992. Requirement of pp60c-scr expression for osteoclasts to form ruffled borders and resorb bone in mice. J. Clin. Invest. 90: 1622-1627.
12. Breel, M., R.E. Mebius, and G. Kraal. 1987. Dendritic cells of the mouse recognized by two monoclonal antibodies. Eur. J. Immunol. 17: 1555-1559.
13. Burkly, L., C. Hession, L. Ogata, C. Relly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of RelB is required for the development of thymic medulla and dendritic cells. Nature 373: 531-536.
14. Carrasco, D., R.P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during lymphoid organ development: Specific expression in dendritic antigen-presenting cells. Development 118: 1221-1231.
15. Carrasco, D., F. Weih, and R. Bravo. 1994. Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development 120: 2991-3004.
16. DeKoning, J., L. DiMolfetto, C. Reilly, Q. Wei, W.L. Havran, and D. Lo. 1997. Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J. Immunol. 158: 2558-2566.
17. Dignam, J.D., R.M. Lebovitz, and R.C. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
18. Doi, T.S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185: 953-961.
19. Duchosal, M.A. 1997. B-cell development and differentiation. Semin. Hematol. 34: 2-12.
20. Farr, A.G. and S.K. Anderson. 1985. Epithelial heterogeneity in the murine thymus: Fucose-specific lectins bind medullary epithelial cells. J. Immunol. 134: 2971-2977.
21. Felix, R., M.G. Cecchini, W. Hofstetter, P.R. Elford, A. Stutzer, and H. Fleisch. 1990. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J. Bone Miner. Res. 5: 781-789.
22. Feuillard, J., M. Koemer, A. Israel, J. Vassy, and M. Raphael. 1996. Differential nuclear localization of p50, p52 and RelB proteins in human accessory cells of the immune response in situ. Eur. J. Immunol. 26: 2547-2551.
23. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition. Nature 359: 339-342.
24. Franzoso, G., V. Bours, V. Azarenko, S. Park, M. Tomita Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 can facilitate NF-κB-mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12: 3893-3901.
25. Franzoso, G., L. Carlson, T. Scharton-Kersten, E.W. Shores, S. Epstein, A. Grinberg, T. Tran, E. Schacter, A. Leonardi, M. Anver, P. Love, A. Sher, and U. Siebenlist. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity 6: 479-490.
26. Franzoso, G., L. Carlson, L. Poljak, E.W. Shores, S. Epstein, A. Leonardi, A. Grinberg, T. Tran, T. Scharton-Kersten, M. Anver, P. Love, K. Brown, and U. Siebenlist. 1998. Mice deficient in NF-κB/p52 present with deficits in humoral responses, germinal center reactions and splenic microarchitecture. J. Exp. Med. (in press).
27. Fujita, T., G.P. Nolan, H.-C. Liou, M.L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator through NF-κB p50 homodimers. Genes & Dev. 7: 1354-1363.
28. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-P. Scheerlinck, and R.J. Grumont. 1996. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. 93: 3405-3409.
29. Grigoriades, A.E., Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, H.A. Fleisch, and E.F. Wagner. 1994. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266: 443-448.
30. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: Distinct roles for Rel in different macrophage populations. EMBO J. 15: 7099-7107.
31. Horowitz, M.C. 1993. Cytokines and estrogen in bone: Antiosteoporotic effects. Science 260: 626-627.
32. Horwitz, B.H., M.L. Scott, S.R. Cherry, R.T. Bronson, and D. Baltimore. 1997. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity 6: 765-772.
33. Hughes, D.E., A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy, and B.F. Boyce. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGFβ. Nature Med. 2: 1132-1136.
34. Jameson, S.C., K.A. Hogquist, and M.J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13: 93-126.
35. Jilka, R., G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Boxmeyer, and S.C. Manolagas. 1992. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257: 88-91.
36. Jimi, E., T. Shuto, and T. Koga. 1995. Macrophage colony-stimulating factor and interleukin la maintain the survival of osteoclast-like cells. Endocrinology 136: 808-811.
37. Kampinga, J., S. Berges, R.L. Boyd, P. Brekelmans, M. Colic, W. vanEwijk, M.D. Kendall, H. Ladyman, P. Nieuwenhusi, and M.A. Ritter. 1989. Thymic epithelial antibodies: Immunohistochemical analysis and introduction of nomenclature. Thymus 13: 165-173.
38. Kimble, R.B., A.B. Matayoshi, J.L. Vannice, C. Williams, and R. Pacfici. 1995. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136: 3054-3061.
39. Kirillov, A., B. Kistler, R. Mostoslavsky, H. Cedar, T. Wirth, and Y. Bergman. 1996. A role for nuclear NF-κB in B-cell specific demethylation of the Igκ locus. Nature Genet. 13: 435-141.
40. Kitazawa, R., R.B. Kimble, J.L. Vannice, V.T. Kung, and R. Pacifici. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94: 2397-2406.
41. Klement, J.F., N.R. Rice, B.D. Car, S.J. Abbondanzo, G.D. Powers, P.H. Bhatt, C.H. Chen, C.A. Rosen, and C.L. Stewart. 1996. IκBα deficiency results in sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell Biol. 16: 2341-2349.
42. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes & Dev. 9: 1965-1977.
43. Lam, K.-P., R. Kühn, and K. Rajewsky. 1997. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90: 1073-1083.
44. Laufer, T.M., J. DeKoning, J.S. Markowitz, D. Lo, and L.H. Glimcher. 1996. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature 383: 81-85.
45. Leenen, P.J., M.F. DeBruijn, J.S. Voerman, P.A. Campbell, and W. vanEwijk. 1994. Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174: 5-19.
46. Liou, H.C., W.C. Sha, M.L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB /Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14: 5349-5359.
47. Liu, Y.-J. and J. Banchereau. 1996. Mutant mice without B lymphocyte follicles. J. Exp. Med. 184: 1207-1211.
48. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87: 565-576.
49. Lowe, C., T. Yoneda, B.F. Boyce, H. Chen, G.R. Mundy, and P. Soriano. 1993. Osteopetrosis in src deficient mice is due to an autonomous defect of osteoclasts. Proc. Natl. Acad. Sci. 90: 4485-4489.
50. MacLennan, I.C.M. 1994. Germinal centers. Annu. Rev. Immunol. 12: 117-139.
51. Melchers, F. 1997. The development of lymphocytes. Int. Arch. Allergy Immunol. 113: 11-13.
52. Melton, L.J. 1995. How many women have osteoporosis now? J. Bone Miner. Res. 10: 175-177.
53. Michaelson, J.S., M. Singh, C.M. Snapper, W.C. Sha, D. Baltimore, and B.K. Birshtein. 1996. Regulation of 3′IgH enhancers by a common set of factors, including κB-binding proteins. J. Immunol. 156: 2828-2839.
54. Minkin, C. 1982. Bone acid phosphatase: Tartrate-resistant acid phosphatse as a marker of osteoclast function. Calcif. Tissue Int. 34: 285-290.
55. Miyamoto, S., M.J. Schmitt, and I.M. Verma. 1994. Qualitative changes inthe subunit composition of κB-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. 91: 5056-5060.
56. Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. Papaionannou. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68: 869-877.
57. Ozaki, K., H. Takeda, H. Iwahashi, A. Kitano, and S. Hanazawa. 1997. NF-κB inhibitors stimulate apoptosis of rabbit mature osteoclasts and inhibit bone resorption by these cells. FEBS Lett. 410: 297-300.
58. Pacifici, R., C. Brown, E. Puschck, E. Friederick, R. McCracken, D. Maggio, E. Slatopolsky, and L.V. Avioli. 1991. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc. Natl. Acad. Sci. 88: 5134-5138.
59. Popoff, S.N. and S.C. Marks, Jr. 1995. The heterogeneity of the osteopetroses reflects the diversity of cellular influences during skeletal development. Bone 17: 437-445.
60. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381: 751-758.
61. Robey, E. and B.J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12: 675-705.
62. Scherer, D.C., J.A. Brockman, H.H. Bendall, G.M. Zhang, D.W. Ballard, and E.M. Oltz. 1996. Corepression of RelA and c-Rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytes. Immunity 6: 563-574.
63. Schwarz, E.M., P. Krimpenfort, A. Berns, and I.M. Verma. 1997. Immunological defects in mice with a argeted disruption in Bcl-3. Genes & Dev. 11: 187-197.
64. Sha, W.C., H.C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disurption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80: 321-330.
65. Shaffer, A.L., A. Peng, and M.S. Schlissel. 1997. In vivo ococupancy of the κ light chain enhancers in primary pro- and pre-B cells: A model for κ locus activation. Immunity 6: 131-143.
66. Shores, E.W., K. Huang, T. Tran, E. Lee, A. Grinberg, and P.E. Love. 1994. Role of TCR chain in T cell development and selection. Science 266: 1047-1050.
67. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
68. Snapper, C.M., F.R. Rosas, R. Zelazowski, M.A. Moorman, M.R. Kehry, R. Bravo, and F. Weih. 1996a. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184: 1537-1541.
69. Snapper, C.M., P. Zelazzowski, F.R. Rosas, M.R. Kehry, M. Tian, D. Baltimore, and W.C. Sha. 1996b. B cells from p50/ NF-κB knock-out mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156: 183-191.
70. Soriano, P., C. Montgomery, R. Geske, and A. Bradley. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
71. Surh, C.D., E.K. Gao, H. Kosaka, D. Lo, C. Ahn, D.B. Murphy, L. Karlsson, P. Peterson, and J. Sprent. 1992. Two subsets of epithelial cells in the thymic medulla. J. Exp. Med. 176: 495-505.
72. Takahashi, N., N. Udagawa, T. Akatsu, H. Tanaka, Y. Isogai, and T. Suda. 1991. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenviornment provided by osteoblastic cells. Endocrinology 128: 1792-1796.
73. Tondravi, M.M., S.R. McKercher, K. Anderson, J.M. Erdmann, M. Quiroz, R. Maki, and S.L. Teitelbaum. 1997. Osteopetrosis in mice lacking haematopoietic transcription factor PU. 1. Nature 386: 81-84.
74. Turner, M., P.J. Mee, P.S. Costello, O. Williams, A.A. Price, L.P. Duddy, M.T. Furlong, R.L. Geahlen, and V.L. Tybulewicz. 1995. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378: 298-302.
75. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
76. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family intimate tales of association and dissociation. Genes & Dev. 9: 2723-2735.
77. Wang, C.Y., M.Y. Mayo, and A.S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787.
78. Wang, Z.-Q., C. OVitt, A.E. Grigoriadis, U. Mohle-Steinlein, U. Ruther, and E.F. Wagner. 1992. Bone and haematopoietic defects in mice lakcing c-Fos. Nature 360: 741-745.
79. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Risszo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80: 331-340.
80. Weih, F., S.K. Durham, D.S. Barton, W.C. Sha, D. Baltimore, and R. Bravo. 1996. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J. Immunol. 157: 3974-3979.
81. _. 1997. p50-NF-κB complexes partially compensate for the absence of RelB: Severely increased pathology in p50(-/ -)relB(-/-) double-knockout mice. J. Exp. Med. 185: 1359-1370.
82. Wu, M., H. Lee, R.E. Bellas, S.L. Schauer, M. Arsura, K. Katz, M.J. FitzGerald, T.L. Rothstein, D.H. Sherr, and G.E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15: 4682-4690.
83. Yoshida, H., S. Hayashi, T. Kunisada, M. Ogawa, S. Nishikawa, H. Okamura, T. Sudo, L.D. Schultz, and S. Nihikawa. 1990. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444.